Bastian Schilling
Goethe University Frankfurt(DE)German Cancer Research Center(DE)University of Würzburg(DE)Essen University Hospital(DE)Universitätsklinikum Würzburg(DE)University Hospital Frankfurt(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)University of Rostock(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Melanoma and MAPK Pathways
Most-Cited Works
- → Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade(2016)3,057 cited
- → Genomic correlates of response to CTLA-4 blockade in metastatic melanoma(2015)2,936 cited
- → A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade(2018)1,406 cited
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,066 cited
- → Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors(2018)689 cited
- → Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab(2016)577 cited